Veradigm Inc (MDRX)
OTCMKTS: MDRX · Delayed Price · USD
7.70
0.00 (0.00%)
May 6, 2024, 3:59 PM EDT - Market closed
Veradigm Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
8,000
Market Cap
828.83M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 0 | - | - |
Dec 31, 2021 | 1.50B | 300.00K | 0.02% |
Dec 31, 2020 | 1.50B | -269.00M | -15.18% |
Dec 31, 2019 | 1.77B | 21.70M | 1.24% |
Dec 31, 2018 | 1.75B | -56.30M | -3.12% |
Dec 31, 2017 | 1.81B | 256.40M | 16.54% |
Dec 31, 2016 | 1.55B | 163.50M | 11.79% |
Dec 31, 2015 | 1.39B | 8.50M | 0.62% |
Dec 31, 2014 | 1.38B | 4.80M | 0.35% |
Dec 31, 2013 | 1.37B | -73.20M | -5.06% |
Dec 31, 2012 | 1.45B | -2.80M | -0.19% |
Dec 31, 2011 | 1.45B | 744.60M | 105.69% |
Dec 31, 2010 | 704.50M | 2.00K | 0.00% |
May 31, 2010 | 704.50M | 320.70M | 83.56% |
May 31, 2008 | 383.80M | 101.89M | 36.14% |
Dec 31, 2007 | 281.91M | 53.94M | 23.66% |
Dec 31, 2006 | 227.97M | 107.41M | 89.09% |
Dec 31, 2005 | 120.56M | 19.79M | 19.64% |
Dec 31, 2004 | 100.77M | 14.93M | 17.39% |
Dec 31, 2003 | 85.84M | 7.04M | 8.93% |
Dec 31, 2002 | 78.80M | 8.05M | 11.37% |
Dec 31, 2001 | 70.75M | 8.07M | 12.87% |
Dec 31, 2000 | 62.69M | 35.09M | 127.13% |
Dec 31, 1999 | 27.60M | 3.90M | 16.46% |
Dec 31, 1998 | 23.70M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 81.80B |
Merck & Co. | 61.40B |
AbbVie | 54.40B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.49B |
Abbott Laboratories | 40.33B |
MDRX News
- 6 days ago - MedEvolve Announces Strategic Marketing Relationship with Veradigm to Enhance Revenue Cycle Management Solutions for Healthcare Organizations - Business Wire
- 27 days ago - Veradigm Network Solution Practice Fusion EHR Receives Top Ambulatory Rankings - Business Wire
- 4 weeks ago - Veradigm and Vim to Improve Payer-Provider Collaboration - Business Wire
- 5 weeks ago - Update in Lawsuit for Investors who purchased shares of Veradigm Inc. (NASDAQ: MDRX) announced by the Shareholders Foundation - PRNewsWire
- 7 weeks ago - Veradigm to Participate in KeyBanc Capital Markets Life Sciences & MedTech Investor Forum - Business Wire
- 7 weeks ago - Veradigm Announces Initial Financial Guidance for Fiscal 2024 - Business Wire
- 2 months ago - Veradigm Completes Acquisition of ScienceIO - Business Wire
- 2 months ago - Veradigm to Participate in TD Cowen Annual Health Care Conference - Business Wire